|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1348934408 |
| 003 |
OCoLC |
| 005 |
20231120010709.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
221027s2022 mau o 000 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d EBLCP
|d OCLCF
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|z 9780323903882
|
| 035 |
|
|
|a (OCoLC)1348934408
|
| 050 |
|
4 |
|a RC268.45
|
| 082 |
0 |
4 |
|a 616.9940654
|2 23
|
| 245 |
0 |
0 |
|a Nutrition and cancer /
|c Edited by Aitziber Buqu�e, Lorenzo Galluzzi
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press,
|c 2022.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a International review of cell and molecular biology ;
|v volume 373
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro -- Nutrition and Cancer -- Copyright -- Contents -- Contributors -- Emergent impact of lifestyle on tumor progression and response to therapy -- Acknowledgments -- Conflict of interest -- References -- Chapter One: Modifying dietary amino acids in cancer patients -- 1. Introduction -- 2. Reducing availability of NEAAs as an anti-cancer approach -- 3. Role of essential AAs in cancer biology -- 4. Altering dietary protein to limit tumor growth and enhance cancer therapy -- 5. Role of bacteria in mediating the pro-tumorigenic effects of dietary AAs
|
| 505 |
8 |
|
|a 6. Current recommendations for protein intake in cancer patients -- 7. Considerations for evaluating the impact of modifying AA intake on treatment response and outcomes in patients with cancer -- Acknowledgments -- Conflicts of interest -- References -- Chapter Two: Targeting amino acid metabolism in cancer -- 1. Introduction -- 2. Asparagine -- 2.1. Asparagine synthetase (ASNS) -- 2.1.1. Catalytic function and structure of ASNS -- 2.1.2. ASNS deficiency -- 2.1.3. ASNS regulation -- 2.2. L-asparaginase (ASNase) -- 2.2.1. ASNase in leukemias and lymphomas -- 2.2.2. ASNase in solid tumors
|
| 505 |
8 |
|
|a 2.2.3. Glutaminase activity of ASNase -- 2.2.4. Limits of the ASNase therapy -- 3. Arginine -- 3.1. Metabolism of arginine -- 3.2. Arginine-nitric oxide pathway -- 3.3. Arginine-ornithine-polyamine pathway -- 3.4. Suitable candidates for arginine-depleting enzyme therapies -- 3.5. Arginine deiminase -- 3.5.1. Arginine deiminase-based therapy -- 3.5.2. Limitations of arginine deiminase therapy -- 3.6. Arginase -- 3.6.1. Arginase therapy -- 3.6.2. Limitations of arginase therapy -- 4. Methionine -- 4.1. Methionine metabolism -- 4.2. The Hoffman effect -- 4.3. Methioninase
|
| 505 |
8 |
|
|a 4.3.1. Methioninase therapy -- 5. Cysteine -- 5.1. Cysteine metabolism -- 5.2. Cyst(e)inase -- 5.2.1. Cyst(e)inase therapy -- 6. Concluding remarks -- Acknowledgments -- References -- Chapter Three: Fasting and cancer: from yeast to mammals -- 1. Introduction -- 2. Calorie restriction -- 3. Fasting and fasting mimicking diets -- 4. Fasting mimicking diets and cancer -- 4.1. Differential stress resistance -- 4.2. Differential stress sensitization -- 4.3. FMD and antitumor immunity -- 5. Fasting-mimicking diets and non-toxic interventions to kill cancer cells
|
| 505 |
8 |
|
|a 5.1. FMD synergizes with high-dose vitamin C to kill KRAS-mutant cancer cells -- 5.2. FMD cycles potentiate hormone therapies and induce breast cancer regression -- 6. Fasting-mimicking diets in clinical oncology -- Acknowledgments -- References -- Chapter Four: Fasting and cancer responses to therapy -- 1. Introduction -- 2. Nutrients restriction in rodents and humans -- 3. Calorie restriction in cancer therapy -- 4. Alternative approaches to fasting and CR in cancer therapy -- 5. Conclusion -- Acknowledgments -- Conflicts of interest -- Authors contribution -- References
|
| 650 |
|
0 |
|a Cancer
|x Nutritional aspects.
|
| 650 |
|
0 |
|a Cancer
|x Cytopathology.
|
| 650 |
|
6 |
|a Cancer
|x Aspect nutritionnel.
|0 (CaQQLa)201-0004689
|
| 650 |
|
6 |
|a Cancer
|x Cytopathologie.
|0 (CaQQLa)201-0209732
|
| 650 |
|
7 |
|a Cancer
|x Cytopathology
|2 fast
|0 (OCoLC)fst00845344
|
| 650 |
|
7 |
|a Cancer
|x Nutritional aspects
|2 fast
|0 (OCoLC)fst00845407
|
| 700 |
1 |
|
|a Buqu�e, Aitziber,
|e editor.
|
| 700 |
1 |
|
|a Galluzzi, Lorenzo,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t NUTRITION AND CANCER.
|d [Place of publication not identified] : ELSEVIER ACADEMIC PRESS, 2022
|z 0323903886
|w (OCoLC)1273677495
|
| 830 |
|
0 |
|a International review of cell and molecular biology ;
|v v. 373.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/19376448/373
|z Texto completo
|
